Capricor Therapeutics | CAPR - Selling And Administration Expenses


Capricor Therapeutics reported $1.92M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Alterity Therapeutics Limited AUD 1.45M 703.96K Dec/2025
Bioline Rx USD 831K 622K Sep/2025
Capricor Therapeutics USD 1.92M 446.47K Dec/2025
Cipla INR 13.25B 101.8M Dec/2025
Cytokinetics USD 104.9M 13.17M Mar/2026
Geron USD 35.42M 6.24M Mar/2026
Grifols EUR 320.45M 12.65M Dec/2025
Immunic USD 3.45M 451K Dec/2025
J&J USD 6.03B 719M Mar/2026
Plus Therapeutics USD 3.49M 559K Dec/2025
Prothena USD 7.65M 5.59M Dec/2025
PTC Therapeutics USD 73.89M 13.31M Mar/2026
Sarepta Therapeutics USD 54.03M 51.35M Mar/2026